Global Bronchiectasis Drugs Market Insights, Forecast to 2029

Publication ID:

PB504232674

Publication Date:

June 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.
Market Analysis and Insights: Global Bronchiectasis Drugs Market
The global Bronchiectasis Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists to precisely identify the stage of the disease and provide appropriate and timely treatment to patients.
Report Includes
This report presents an overview of global market for Bronchiectasis Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Bronchiectasis Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bronchiectasis Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bronchiectasis Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Bronchiectasis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Bronchiectasis Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Endo International Plc, GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc. and Reckitt Benckiser Group Plc, etc.
By Company
Endo International Plc
GlaxoSmithKline Plc
Neopharma LLC
Pfizer Inc.
Reckitt Benckiser Group Plc
Segment by Type
Antibiotics
Expectorants
Other drugs
Segment by Application
Hospital
Research institute
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Bronchiectasis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bronchiectasis Drugs companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bronchiectasis Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antibiotics
1.2.3 Expectorants
1.2.4 Other drugs
1.3 Market by Application
1.3.1 Global Bronchiectasis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research institute
1.3.4 Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bronchiectasis Drugs Market Perspective (2018-2029)
2.2 Global Bronchiectasis Drugs Growth Trends by Region
2.2.1 Bronchiectasis Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bronchiectasis Drugs Historic Market Size by Region (2018-2023)
2.2.3 Bronchiectasis Drugs Forecasted Market Size by Region (2024-2029)
2.3 Bronchiectasis Drugs Market Dynamics
2.3.1 Bronchiectasis Drugs Industry Trends
2.3.2 Bronchiectasis Drugs Market Drivers
2.3.3 Bronchiectasis Drugs Market Challenges
2.3.4 Bronchiectasis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bronchiectasis Drugs by Players
3.1.1 Global Bronchiectasis Drugs Revenue by Players (2018-2023)
3.1.2 Global Bronchiectasis Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bronchiectasis Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Bronchiectasis Drugs Market Concentration Ratio
3.4.1 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Drugs Revenue in 2022
3.5 Global Key Players of Bronchiectasis Drugs Head office and Area Served
3.6 Global Key Players of Bronchiectasis Drugs, Product and Application
3.7 Global Key Players of Bronchiectasis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchiectasis Drugs Breakdown Data by Type
4.1 Global Bronchiectasis Drugs Historic Market Size by Type (2018-2023)
4.2 Global Bronchiectasis Drugs Forecasted Market Size by Type (2024-2029)
5 Bronchiectasis Drugs Breakdown Data by Application
5.1 Global Bronchiectasis Drugs Historic Market Size by Application (2018-2023)
5.2 Global Bronchiectasis Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bronchiectasis Drugs Market Size (2018-2029)
6.2 North America Bronchiectasis Drugs Market Size by Type
6.2.1 North America Bronchiectasis Drugs Market Size by Type (2018-2023)
6.2.2 North America Bronchiectasis Drugs Market Size by Type (2024-2029)
6.2.3 North America Bronchiectasis Drugs Market Share by Type (2018-2029)
6.3 North America Bronchiectasis Drugs Market Size by Application
6.3.1 North America Bronchiectasis Drugs Market Size by Application (2018-2023)
6.3.2 North America Bronchiectasis Drugs Market Size by Application (2024-2029)
6.3.3 North America Bronchiectasis Drugs Market Share by Application (2018-2029)
6.4 North America Bronchiectasis Drugs Market Size by Country
6.4.1 North America Bronchiectasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Bronchiectasis Drugs Market Size by Country (2018-2023)
6.4.3 North America Bronchiectasis Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Bronchiectasis Drugs Market Size (2018-2029)
7.2 Europe Bronchiectasis Drugs Market Size by Type
7.2.1 Europe Bronchiectasis Drugs Market Size by Type (2018-2023)
7.2.2 Europe Bronchiectasis Drugs Market Size by Type (2024-2029)
7.2.3 Europe Bronchiectasis Drugs Market Share by Type (2018-2029)
7.3 Europe Bronchiectasis Drugs Market Size by Application
7.3.1 Europe Bronchiectasis Drugs Market Size by Application (2018-2023)
7.3.2 Europe Bronchiectasis Drugs Market Size by Application (2024-2029)
7.3.3 Europe Bronchiectasis Drugs Market Share by Application (2018-2029)
7.4 Europe Bronchiectasis Drugs Market Size by Country
7.4.1 Europe Bronchiectasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Bronchiectasis Drugs Market Size by Country (2018-2023)
7.4.3 Europe Bronchiectasis Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bronchiectasis Drugs Market Size (2018-2029)
8.2 China Bronchiectasis Drugs Market Size by Type
8.2.1 China Bronchiectasis Drugs Market Size by Type (2018-2023)
8.2.2 China Bronchiectasis Drugs Market Size by Type (2024-2029)
8.2.3 China Bronchiectasis Drugs Market Share by Type (2018-2029)
8.3 China Bronchiectasis Drugs Market Size by Application
8.3.1 China Bronchiectasis Drugs Market Size by Application (2018-2023)
8.3.2 China Bronchiectasis Drugs Market Size by Application (2024-2029)
8.3.3 China Bronchiectasis Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bronchiectasis Drugs Market Size (2018-2029)
9.2 Asia Bronchiectasis Drugs Market Size by Type
9.2.1 Asia Bronchiectasis Drugs Market Size by Type (2018-2023)
9.2.2 Asia Bronchiectasis Drugs Market Size by Type (2024-2029)
9.2.3 Asia Bronchiectasis Drugs Market Share by Type (2018-2029)
9.3 Asia Bronchiectasis Drugs Market Size by Application
9.3.1 Asia Bronchiectasis Drugs Market Size by Application (2018-2023)
9.3.2 Asia Bronchiectasis Drugs Market Size by Application (2024-2029)
9.3.3 Asia Bronchiectasis Drugs Market Share by Application (2018-2029)
9.4 Asia Bronchiectasis Drugs Market Size by Region
9.4.1 Asia Bronchiectasis Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Bronchiectasis Drugs Market Size by Region (2018-2023)
9.4.3 Asia Bronchiectasis Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Bronchiectasis Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Endo International Plc
11.1.1 Endo International Plc Company Details
11.1.2 Endo International Plc Business Overview
11.1.3 Endo International Plc Bronchiectasis Drugs Introduction
11.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2018-2023)
11.1.5 Endo International Plc Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2018-2023)
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Neopharma LLC
11.3.1 Neopharma LLC Company Details
11.3.2 Neopharma LLC Business Overview
11.3.3 Neopharma LLC Bronchiectasis Drugs Introduction
11.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2018-2023)
11.3.5 Neopharma LLC Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Bronchiectasis Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2018-2023)
11.4.5 Pfizer Inc. Recent Developments
11.5 Reckitt Benckiser Group Plc
11.5.1 Reckitt Benckiser Group Plc Company Details
11.5.2 Reckitt Benckiser Group Plc Business Overview
11.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Introduction
11.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2018-2023)
11.5.5 Reckitt Benckiser Group Plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Endo International Plc
GlaxoSmithKline Plc
Neopharma LLC
Pfizer Inc.
Reckitt Benckiser Group Plc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂